Home » Topics » BioWorld Science

BioWorld Science
RSS

NaviCyte and SmithKline Beecham enter drug discovery collaboration

Dec. 2, 1997

Takeda's PAF antagonist evaluated in preclinical model of asthma

Dec. 2, 1997

Angiostatin production mechanism elucidated; may permit large-scale studies

Dec. 2, 1997

Company Profile: Cor Therapeutics

Dec. 2, 1997

Biomira withdraws NDS for Tru-Scint imaging kit

Dec. 1, 1997

U.S. patent covers new melanoma antigen/MAb discovered by Cytoclonal

Dec. 1, 1997

Phase I/II clinical trial of gene therapy for melanoma

Dec. 1, 1997

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

IL-2 gene therapy for metastatic solid tumors: phase I results

Dec. 1, 1997

New anesthetic agent in phase I at Synthelabo

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...